当前位置:首页 - 行情中心 - 凯马B(900953) - 财务分析 - 利润表

凯马B

(900953)

  

流通市值:720.00万  总市值:1920.00万
流通股本:2.40亿   总股本:6.40亿

利润表

报告期2025-06-302024-12-312024-06-302024-03-31
公司类型通用通用通用通用
一、营业总收入890,751,696.392,505,541,767.631,537,858,980.47831,218,985.62
  营业收入890,751,696.392,505,541,767.631,537,858,980.47831,218,985.62
二、营业总成本956,408,838.92,638,174,067.891,573,658,390.3845,249,179.6
  营业成本878,116,487.172,431,856,227.711,464,364,465.84789,242,235.02
  税金及附加5,910,574.3111,959,798.926,207,473.272,906,248.56
  销售费用7,623,077.728,399,303.0417,526,939.1510,206,084.85
  管理费用28,362,828.6786,576,138.642,687,365.0823,133,997.79
  研发费用27,048,031.0653,147,306.8230,362,182.3913,837,920.27
  财务费用9,347,839.9926,235,292.812,509,964.575,922,693.11
  其中:利息费用11,930,857.9633,307,300.6516,935,574.738,206,913.93
  其中:利息收入2,313,801.615,167,193.232,620,015.191,617,895.74
三、其他经营收益
  加:投资收益--131,897,324.46--
  资产处置收益871,807.362,117,690.23-10,479.58-8,573.13
  资产减值损失(新)-2,813,713.66-8,773,923.25156,156.25-
  信用减值损失(新)392,657.13-12,811,487.71119,173.6250,000
  其他收益25,576,006.5759,514,436.0733,964,872.8215,745,949.12
四、营业利润-41,630,385.11-224,482,909.38-1,569,686.721,757,182.01
  加:营业外收入7,972,274.79136,216.4947,929.0938,105.09
  减:营业外支出436,797.69752,214.17385,535.189,032.07
五、利润总额-34,094,908.01-225,098,907.06-1,907,292.731,706,255.03
  减:所得税费用5,252,994.4716,459,640.2911,934,154.736,520,529.5
六、净利润-39,347,902.48-241,558,547.35-13,841,447.46-4,814,274.47
(一)按经营持续性分类
  持续经营净利润-39,347,902.48-241,558,547.35-13,841,447.46-4,814,274.47
(二)按所有权归属分类
  归属于母公司股东的净利润-35,114,632.37-234,542,039.26-21,690,943.19-9,730,661.1
  少数股东损益-4,233,270.11-7,016,508.097,849,495.734,916,386.63
  扣除非经常损益后的净利润-45,974,791.15-118,213,989.36-46,673,898.43-14,528,177.56
七、每股收益
  (一)基本每股收益-0.05-0.37-0.03-0.02
  (二)稀释每股收益--0.37--0.02
九、综合收益总额-39,347,902.48-241,558,547.35-13,841,447.46-4,814,274.47
  归属于母公司股东的综合收益总额-35,114,632.37-234,542,039.26-21,690,943.19-9,730,661.1
  归属于少数股东的综合收益总额-4,233,270.11-7,016,508.097,849,495.734,916,386.63
公告日期2025-08-282025-04-292024-08-282024-04-26
审计意见(境内)标准无保留意见
TOP↑